AlO(OH)-polymer nanoparticles |
|
Vaxjo ID |
344 |
|
Vaccine Adjuvant Name |
AlO(OH)-polymer nanoparticles |
|
Adjuvant VO ID |
VO_0005270
|
|
Description |
Aluminum hydroxide is a classical gel-like immune adjuvant. The paper describes AlO(OH)-polymer nanoparticles (APNs), which are nano-sized vaccine carriers derived from aluminum hydroxide, designed to promote lymphatic migration and amplify CD8+ T cell responses. |
|
Stage of Development |
Licensed |
|
Host Species for Testing |
Human |
|
Structure |
The classical adjuvant is described as "gel-like". The new formulation is "nano-sized vaccine carriers AlO(OH)-polymer nanoparticles (APNs)". |
|
Appearance |
The classical adjuvant is described as "gel-like". |
|
Preparation |
Aluminum hydroxide is "turned from gel into nano-sized vaccine carriers AlO(OH)-polymer nanoparticles (APNs)". |
|
Function |
aluminum hydroxide is turned from gel into nano-sized vaccine carriers AlO(OH)-polymer nanoparticles (APNs) to promote their lymphatic migration. |
|
Safety |
Aluminum hydroxide has been used as an immune adjuvant in human vaccines for over 80 years due to its safety and efficacy. |
| Related Vaccine(s) |
|
| References |
Jiang et al., 2018: Jiang H, Wang Q, Li L, Zeng Q, Li H, Gong T, Zhang Z, Sun X. Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8(+) T Cell Responses. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2018; 5(1); 1700426. [PubMed: 29375970].
|
